News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
449,069 Results
Type
Article (38416)
Company Profile (154)
Press Release (410499)
Section
Business (137954)
Career Advice (1401)
Deals (22605)
Drug Delivery (78)
Drug Development (49026)
Employer Resources (149)
FDA (7979)
Job Trends (9847)
News (218472)
Policy (16592)
Tag
Academia (2096)
Alliances (32896)
Alzheimer's disease (961)
Approvals (7961)
Artificial intelligence (127)
Bankruptcy (158)
Best Places to Work (7756)
Biotechnology (100)
Breast cancer (133)
Cancer (971)
Cardiovascular disease (88)
Career advice (1184)
CAR-T (85)
Cell therapy (219)
Clinical research (38078)
Collaboration (410)
Compensation (173)
COVID-19 (1664)
C-suite (121)
Data (1049)
Diabetes (114)
Diagnostics (4334)
Earnings (50979)
Employer resources (132)
Events (72241)
Executive appointments (378)
FDA (8409)
Funding (380)
Gene therapy (144)
GLP-1 (434)
Government (2147)
Healthcare (11198)
Infectious disease (1724)
Inflammatory bowel disease (92)
Interviews (201)
IPO (10766)
Job creations (2418)
Job search strategy (1062)
Layoffs (261)
Legal (3796)
Lung cancer (141)
Manufacturing (142)
Medical device (7063)
Medtech (7068)
Mergers & acquisitions (12066)
Metabolic disorders (315)
Neuroscience (1216)
NextGen: Class of 2025 (3949)
Non-profit (2875)
Northern California (1302)
Obesity (180)
Opinion (138)
People (45494)
Phase I (11632)
Phase II (16512)
Phase III (13291)
Pipeline (439)
Postmarket research (1498)
Preclinical (6233)
Radiopharmaceuticals (170)
Rare diseases (176)
Real estate (4128)
Regulatory (11503)
Research institute (1964)
Resumes & cover letters (216)
Southern California (1049)
Startups (2843)
United States (10895)
Vaccines (301)
Weight loss (115)
Date
Today (75)
Last 7 days (591)
Last 30 days (1440)
Last 365 days (24293)
2025 (918)
2024 (24485)
2023 (28278)
2022 (35762)
2021 (38986)
2020 (36134)
2019 (29248)
2018 (21937)
2017 (21867)
2016 (21105)
2015 (25617)
2014 (20599)
2013 (17438)
2012 (16796)
2011 (17383)
2010 (16650)
Location
Africa (572)
Arizona (112)
Asia (25247)
Australia (4397)
California (2819)
Canada (1094)
China (177)
Colorado (127)
Connecticut (144)
Europe (60129)
Florida (358)
Georgia (81)
Illinois (220)
Indiana (173)
Japan (82)
Maryland (339)
Massachusetts (2282)
Michigan (157)
Minnesota (176)
New Jersey (802)
New York (864)
North Carolina (578)
Northern California (1302)
Ohio (105)
Pennsylvania (576)
South America (742)
Southern California (1049)
Texas (387)
Utah (90)
Washington State (249)
449,069 Results for "sanmina sci corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results
CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended March 31, 2024, as well as key recent clinical and corporate developments.
May 16, 2024
·
7 min read
Press Releases
CEL-SCI Announces Closing of $5 Million Offering
January 1, 2025
·
4 min read
Press Releases
CEL-SCI Announces Proposed Public Offering of Common Stock
December 29, 2024
·
4 min read
Press Releases
CEL-SCI Announces Pricing of $5 Million Public Offering
December 29, 2024
·
4 min read
Business
Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor
CEL-SCI Corporation announced Dr. Giovanni Selvaggi, an oncology key opinion leader instrumental in successfully bringing several drugs to market has joined CEL-SCI as a Clinical Advisor.
June 6, 2024
·
7 min read
Business
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
CEL-SCI Corporation reported financial results for the quarter ended December 31, 2023, as well as key recent clinical and corporate developments.
February 15, 2024
·
7 min read
Business
CEL-SCI Appoints Mario Gobbo to Its Board of Directors
CEL-SCI Corporation announced the appointment of Mario Gobbo to its Board of Directors. Mr. Gobbo has nearly 40 years of banking and corporate finance experience in healthcare and energy.
April 23, 2024
·
4 min read
Business
CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments
CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2023, as well as key clinical and corporate developments.
December 22, 2023
·
8 min read
Press Releases
CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer
January 14, 2025
·
7 min read
BioCapital
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
CEL-SCI Corporation (NYSE American: CVM) today announced the peer reviewed scientific journal Frontiers in Immunology published an article regarding CEL-SCI’s Ligand Epitope Antigen Presentation System (LEAPS).
March 19, 2024
·
5 min read
1 of 44,907
Next
